Tradestie Institutional Equity Comparison Engine

EDIT vs CADL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CADL Overall Edge

CADL Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Candel Therapeutics, Inc. Common Stock (CADL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EDIT trades at N/M Forward P/E with -167.0% operating margin (+37.4% YoY revenue) versus CADL at 43.5x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro) against CADL sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CADL
EDIT N/M vs CADL 43.5x Fwd P/E
Growth & Margin Winner CADL
Op Margin -167.0% vs 0.0% ยท YoY +37.4% vs +0.0%
Momentum & Technical Winner CADL
1Y -25.0% vs +32.9% ยท 52W Pos 11% vs 18%
Options & Structure Winner CADL
BREAKDOWN (38th %ile IV) vs BREAKDOWN (18th %ile IV)
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 40.0 Fund 54.0 Flow 69.0 Mom 60.0
CADL NASDAQ
Candel Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$6.12
-1.21% 1D
Market Cap $642.0M
1M Return -25.21%
1Y Return +32.86%
Forward P/E 43.5x
Unified AI Score
46.0 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 70.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EDIT -25.0% CADL +32.86% Spread: +57.86 pp (CADL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EDIT Revenue CADL Revenue EDIT Op. Margin CADL Op. Margin Margin Edge
FY2018 $30M N/A -356.1% N/A EDIT
FY2019 $20M N/A -686.4% N/A EDIT
FY2020 $90M $0M -148.6% -11048.0% EDIT
FY2021 $30M $0M -756.1% -20580.8% EDIT
FY2022 $20M $0M -1146.3% -27777.6% EDIT
FY2023 $80M N/A -216.6% N/A EDIT
FY2024 $30M N/A -777.2% N/A EDIT
FY2025 $40M N/A -394.9% N/A EDIT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EDIT (3) vs CADL (7)
Institutional Metric EDIT CADL Criterion Row Winner
Market Capitalization Scale $336.5M $642.0M Larger Scale CADL
Trailing P/E Ratio Valuation N/M 43.5x Lower Multiple CADL
Forward P/E Ratio Valuation N/M 43.5x Lower Multiple CADL
Revenue Growth (YoY) Growth +37.4% +0.0% Higher Growth EDIT
Operating Margin (TTM) Profitability -167.0% 0.0% Higher Margin CADL
Net Profit Margin Profitability -144.9% 0.0% Higher Margin CADL
Return on Equity (ROE) Capital Efficiency -147.4% -93.7% Higher ROE CADL
52-Week Range Position Momentum 11% ($2โ€“$4) 18% ($4โ€“$14) Stronger Trend CADL
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 102% Vol 2.14ฮฒ ยท 125% Vol Lower Realized Risk EDIT
Unified Institutional Score Composite Signal 51.6 / 100 (HOLD) 46.0 / 100 (HOLD) Higher Composite EDIT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EDIT vs CADL Buy Guide
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CADL BREAKDOWN
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live CADL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EDIT nor CADL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.